Table 1 Drugs currently approved by U.S. FDA to treat IPF patients - Journal of Pharmaceutical Compounding and Therapeutics

Journal of Pharmaceutical
Compounding and Therapeutics

Advancing Science Together: An Online Quarterly Peer-Reviewed Open Access Journal

ISSN 2996-3753 (Online)

Journal Overview

For Authors

For Reviewers

For Editors

Articles JPCTS

(2024) Volume 1

Issue 1

Issue 2

Issue 3

Issue 4

(2025) Volume 2

(2026) Volume 3

Issue 1

Submit Your Article

Table 1 Drugs currently approved by U.S. FDA to treat IPF patients

Table 1 Drugs currently approved by U.S. FDA to treat IPF patients

June 15, 2024 / June 15, 2024 by faisal | Leave a comment

single

IPF Pipeline: What is the Current and Future Status on Idiopathic Pulmonary Fibrosis Drug Development?

Leave a Comment Cancel
Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Sidebar

Search

Articles
Articles

Home

Journal Overview

For Reviewers

For Authors

For Editors

Publisher’s Note

Americans with Disabilities (ADA)

Advertisements Policy

Privacy Policy

Any Questions?

© 2026 Journal of Pharmaceutical Compounding and Therapeutics PSciP Publishing LLC, Oakwood, VA, USA/JPCTs. Articles published in this journal are licensed under Attribution 4.0 International

To top